Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Heron Therapeutics Inc (NASDAQ: HRTX) closed at $1.97 in the last session, up 5.35% from day before closing price of $1.87. In other words, the price has increased by $5.35 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
We take a closer look at HRTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.76 and its Current Ratio is at 2.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.02.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -9.20%, while the 200-Day Moving Average is calculated to be 4.86%.
Shares Statistics:
A total of 152.43M shares are outstanding, with a floating share count of 151.14M. Insiders hold about 0.93% of the company’s shares, while institutions hold 81.99% stake in the company.
